The expression of lymphotoxin (LT) 
Introduction
Lymphotoxin (LT)' is a cytokine identified initially as a cytotoxic factor produced by mitogen-or antigen-stimulated T cells (1, 2) . Recent studies have shown that LT is highly homologous to tumor necrosis factor (TNF) and shares a number of biologic activities with TNF (see reviews in references 3 and 4). LT and TNF stimulate B and T lymphocyte proliferation (5) (6) (7) , neutrophil respiratory burst and degranulation (8, 9) , and osteoclast bone resorption (8, 10) . They also induce inflammatory reactions in normal skin (8, 1 1) , and have antiviral effects (12) . In humans, T lymphocytes have been considered the major LT-producing cell type (3) . EBV-transformed B cell lines, however, are good sources of LT.
The production of LT by primary B cells has not been extensively examined. Recently, B1-bearing tonsillar B cells have been demonstrated to secrete an LT-like product (13) . Tonsillar B lymphocytes can also produce TNF (14) . In view of the close homology and tandem arrangement of LT and TNF genes (2, 8) , it is of interest to examine LT production by B cells and compare the regulation of the syntheses of the two cytokines by B cells. Our data presented in this report demonstrate that (a) tonsillar B cells and B cell lines accumulate LT mRNA and synthesize LT when appropriately stimulated, (b) there are differences in the kinetics of LT and TNF mRNA accumulation in B cells, and (c) there are differences in stimulation requirements for LT production and in the kinetics of LT mRNA expression between tonsillar B cells and B cell lines.
Methods
Reagents. The preparation of goat anti-it and rabbit anti-LT antisera has been described (14, 15) . The LT antiserum has 1 X 106neutralizing units/ml. B cell growth factor (BCGF) was obtained from Cellular Products (Cambridge, MA). The sources of other reagents have been described (14) . Cyclosporine A (CsA) was from Sandoz Inc. (East Hanover, NJ).
Cells. Tonsillar B cells were purified and maintained in RPMI-1640 with 10% FCS as described (16) . Purified B cell preparations contained < 0.1% macrophages and > 95% Ig' and > 98% Bl' cells, as determined by fluorescence measurements on a flow cytometer (Cytofluorograf Ils, Ortho Diagnostic Systems, Inc., Westwood, MA). Tonsillar T cells were isolated by E-rosetting twice. These cells were > 95% CD2' and CD3'. The sources and surface Ig phenotypes of the B cell lines used were described previously (14) .
Northern blot analyses. Methods for Northern blot analyses using RNA prepared by guanidinium thiocyanate ultracentrifugation have been described (16 Other methods. The L-cell cytotoxicity assay for LT and TNF was carried out as described ( 16) . For neutralization studies, samples were mixed with anti-LT antiserum (1 X 106 neutralization units/ml) at 2 X 104 U/ml or anti-TNF MAb (F12 [16] ) at 20 ug/ml (the neutralization activity of F12 is 20 ng TNF/jig Ab) overnight before the serial dilutions and addition to the L cells.
Results
LT mRNA expression in tonsillar B cells stimulated by PMA, SAC, anti-M, and BCGF. Tonsillar B cells were stimulated by the combination of various B cell mitogens and examined for LT mRNA accumulation at 24 h. SAC and PMA stimulated low levels of LT mRNA expression ( Fig. 1 A, lane 2 ; B, lanes I and 2; C, lane 3), while anti-si ( Fig. 1 C, lane 2) and BCGF (not shown) did not cause any detectable LT mRNA expression. However, the actions of several of them were synergistic. Like the T cell system (16) , in which two signals were required for the induction of lymphokine production, the stimulation of high levels of LT mRNA accumulation required the combination of SAC or anti-sg with PMA ( Fig. 1 A, lane 3 (Fig. 1 A, lane 6 ), or anti-s plus PMA (Fig. 1 C, lane 7) . Anti-,u antagonized the effect of SAC on LT mRNA accumulation in tonsillar B cells, and abolished LT mRNA production in B cells stimulated with SAC or SAC plus BCGF ( Fig. 1 A, lanes 4 and 7) . Experiments in which the stimulatory potency ofSAC plus PMA and anti-it plus PMA were compared ( Fig. 1 B, lanes 3 and 4) showed that anti-s plus PMA was slightly higher at 24 h.
LT mRNA expression in B cell lines. LT mRNA accumulation was examined in a number of B cell lines expressing different Ig phenotypes (Fig. 2 A) . Most of them expressed undetectable to low levels of LT mRNA constitutively. With PMA stimulation, most cell lines expressed LT mRNA. SeD, 8866p, 32al, and RPMI 1788 expressed high levels of LT mRNA with RPMI 1788 expressing four-to fivefold more than the other three cell lines. Of interest is the finding that the pre-B cell lines Nalm-6 and Nalm-12 did not express LT message even when stimulated by PMA (Fig. 2 A, lanes 16 and 18) fl-actin mRNA which reflected the total intracellular mRNA level also increased with time and reached peak values between 40 and 48 h. If the actin mRNA level in the B cells was taken into account, and the specific increase in LT mRNA expression was determined by taking the ratio ofthe intensities ofLT and actin mRNA bands, an early peak at 8 h was observed for both LT and TNF mRNA accumulation (Fig. 4 B) . A second peak of specific mRNA accumulation was found at 48 h and 32 h for LT and TNF mRNA, respectively.
The stimulation of B cells by PMA plus SAC and PMA plus anti-A to express LT and TNF mRNA was compared in time course studies ( Fig. 3 B , quantitation data not shown). Both combinations of stimuli induced peak LT mRNA accumulation on the second day. PMA plus SAC caused a two-to threefold higher peak LT mRNA level upon PMA stimulation (Fig. 2 A) was chosen for time course studies. LT mRNA accumulation in this cell line stimulated with the protein kinase C activator PMA reached peak level at 6-8 h (Fig. 5) , and decreased slightly between 8 and 48 h after stimulation. When a second signal in the form of cytosolic free [Ca2+] elevation was delivered by the ionophore A23 187, LT mRNA level equal to that of peak accumulation in PMA-stimulated cells was reached between 2 and 4 h. There was a slow twofold increase over the next 20-h period and the peak LT mRNA level was maintained up to 48 h after stimulation. There were notable differences in the time course of TNF and LT mRNA accumulation in these cells treated with the same stimuli (Fig. 5) . PMA-stimulated TNF mRNA accumulation reached peak level earlier (by 1 h), and decreased much more rapidly than LT mRNA accumulation. A23187, when added to PMA stimulated cells, caused a twoto threefold increase in TNF mRNA. It seemed that TNF mRNA was either more unstable than LT mRNA, or its synthesis was terminated earlier.
Comparison ofLT and TNF mRNA expression in tonsillar B and T cells. The expression of LT and TNF mRNA in tonsillar B cells stimulated with PMA plus SAC and PMA plus anti-M were compared with that in tonsillar T cells stimulated with PMA plus anti-CD3 and PHA. The Northern blots of mRNA from these cells stimulated for 32 and 48 h, the approximate time of the second peak of LT and TNF mRNA accumulation, were shown in Fig. 6 A. As discussed in the previous paragraph (Fig. 3 B) , tonsillar B cells stimulated with PMA plus SAC accumulated twice as much LT mRNA as those stimulated with PMA plus anti-M at 48 h (Fig. 6 A, compare lanes I and 2 with lanes 3 and 4). For the T cells, PMA plus anti-CD3 was a better set of stimuli than PHA in inducing LT mRNA accumulation, in part because these cells were extensively purified of macrophages. On a per cell basis, the LT mRNA expression ofT cells stimulated with PMA plus anti-CD3 was two-to threefold higher than that of B cells stimulated with PMA plus SAC (Fig. 6 A, compare lanes I and 2 with lanes 5 and 6). The relative amounts of TNF mRNA expressed in B cells relative to that in T cells, however, were different. B cells could express one-half (14) to slightly larger amounts (Fig. 6 A) of TNF mRNA as T cells, depending upon the individual tonsil examined.
To show that the LT and TNF mRNA detected in these B cell preparations were not due to minor T cell contaminations, tonsillar T cells were stimulated with the B cell mitogen combination PMA and SAC. These T cells did not respond well to these stimuli, and expressed little LT and TNF mRNA (Fig. 6   B) . These results support the notion that the tonsillar B cells were the source of the cytokine mRNA detected in the B cell preparations. 3 and 4) for 32 or 48 h. The same number of tonsillar T cells were also stimulated for the same period of time with PMA (10 ng/ml) plus anti-CD3 (1I Ag/ml) or PHA alone (10 tig/ml).
Northern blot analyses of the samples were performed as in Fig. 1 (Fig. 7 B, lanes 6 and 7) . At 100 ng/ml CsA, a 96% decrease in LT mRNA accumulation was observed. On the other hand, LT mRNA level in B cells stimulated with SAC, PMA, SAC plus BCGF and SAC plus PMA were unaffected by CsA at concentrations of 100 and 500 ng/ml (Fig. 7 A) . At a higher dose of 5 ,gg/ml, LT mRNA levels in these B cells were inhibited 50-70% (not shown). Anti-M plus PMA stimulation, however, was more sensitive to CsA inhibition, and CsA at 500 ng/ml inhibited LT mRNA accumulation in these B cells by 60% (Fig. 7 A, lane 13) .
Production ofLT by tonsillar B cells and B cell lines. The production of LT by tonsillar B cells and B cell lines was determined by L-cell cytotoxicity assays (15) . Tonsillar B cells stimulated with PMA plus anti-g synthesized 30-60 U of LT per 106 cells over a 3-d period (Table I) . Over the same period of time, cells stimulated with PMA plus SAC synthesized about three times as much LT. By comparison, T cells stimulated with PMA plus anti-CD3 synthesized two to three times more LT than B cells stimulated maximally with PMA plus anti-M plus SAC. Control experiments showed that the anti-LT antiserum used did not affect the cytotoxicity of rTNF. Furthermore, rabbit anti-TNF antiserum and anti-TNF mAb F12 had little blocking activity on the cytotoxic activities in these supernatants (data not shown), showing that the majority of the cytotoxic activities were due to LT.
The production of LT by EBV-transformed B cell lines was also examined (Table II) . LT production by cell lines stimulated with PMA with or without the addition of A23 187 was similar. These cell lines expressed in the range of 400-900 U of LT activity per 106 cells over a 24-h period. RPMI 1788 produced the most LT, as has been reported (3). The other two EBV-transformed lines produced about half as much LT as RPMI 1788.
Discussion
LT and TNF genes are highly homologous, similar in gene segment organization and separated by only 1.2 kb on human chromosome 6 (17). For these reasons, they are postulated to belong to the same gene family (3) . We recently demonstrated that B cells synthesized TNF (14) and Bersani et al. (13) reported the presence of LT-like products in stimulated tonsillar B cell supernatants. These data led us to examine the stimulation of LT mRNA expression and cytokine synthesis in B cells. We found that LT mRNA was expressed in tonsillar B cells stimulated by a variety of B cell mitogens. The detection ofLT mRNA by the LT genomic probe was corroborated by the use of two 24-mer LT antisense oligonucleotide probes in Northern blot analyses under high-stringency conditions. The low responses oftonsillar T cells to the B cell mitogen combination PMA plus anti-is confirmed that this LT mRNA detected in stimulated B cells was not due to contaminating T cells. The use of the LT-specific antisera confirmed the presence of LT cytotoxic activities in the supernatants of stimulated B cells. Thus, it now appears that B cells are an important cell type in producing LT, in addition to the production ofTNF (14), IL-I (19) , (20) , and IFN-a (21).
A number of differences were observed when examining LT and TNF mRNA expression characteristics in tonsillar B cells and B cell lines stimulated by a variety ofB cell mitogens. First, as in T cells (14), peak accumulation of TNF mRNA occurred earlier than that of LT mRNA in both tonsillar B cells and B cell lines. Secondly, it appeared that tonsillar B cells played a slightly more significant role in producing TNF than LT. On a per cell basis, tonsillar T cells accumulated two to four times more LT mRNA but less than twofold higher level of TNF mRNA than tonsillar B cells (14, Fig. 6 observed in the T cell lines Molt-4 and Jurkat (16) . Lastly, in the cell line RPMI 1788 stimulated with PMA plus A23187, LT mRNA level remained elevated for more than 2 d whereas TNF mRNA decayed rapidly (Fig. 5) . (Fig. 5) . PMA alone was enough to induce high levels of LT mRNA expression, and the additional activation by the second signal A23187 only slightly increased peak LT mRNA expression (Fig. 5) . This difference also occurred with the expression of TNF mRNA by the same B cell line (Fig. 5) , and with the expression of both LT and TNF genes in T cell lines (16) . The addition of A23187 did, however, reduce the lag time for peak LT and TNF mRNA accumulation in B cell lines, and prolonged the half-life of intracellular message for both cytokines. Whether this kinetic change is due to increased transcription rates of the two genes, or the reduced degradation rates of the mRNA's requires further studies.
The cytotoxic activities of the supernatants of activated tonsillar B cells were predominantly due to LT (Table I) . However, Northern blot studies showed that using TNF and LT mRNA expression by tonsillar T cells as the reference, these B cells accumulate more TNF mRNA than LT mRNA (Fig. 6 ). This paradoxical observation can be explained by the hypothesis that TNF is selectively utilized by the stimulated B cells. This hypothesis is based on the findings that (a) the same receptors that bind both LT and TNF have a tenfold lower binding affinity for LT (25) , (b) LT has a 10-fold higher threshold concentration than TNF in stimulating endothelial cell secretion of IL-1 and hematopoietic growth factors (25, 26) ; and (c) TNF is rapidly utilized by stimulated tonsillar B cells (14). Since both LT and TNF were required for B cell proliferation (5) (6) (7) , experiments designed to prove this hypothesis by blocking LT and TNF reutilization would be difficult to interpret.
Results on CsA inhibition studies (Fig. 7 B) showed that LT mRNA accumulation in PMA plus anti-CD3-stimulated tonsillar T cells was exquisitely sensitive to CsA inhibition. LT mRNA accumulation was almost completely inhibited by 100 ng/ml CsA (Fig. 7 B, lane 6) . This is similar to the proliferation ofperipheral blood T cells stimulated by PMA plus anti-CD3, which was almost completely inhibited by 100 ng/ml CsA (27) . CsA has been shown to inhibit tonsillar B cell proliferation (18) . However, the present study showed that the stimulated increase in LT mRNA accumulation in tonsillar B cells was relatively insensitive to CsA inhibition when compared with that in T cells. A similar resistance to CsA inhibition has also been demonstrated in the stimulated increases of several inducible monocyte mRNAs (28) . Whether this resistance is due to differences in cell types or in the signals elicited by the different stimuli needs to be further examined.
